NCT06126731 2025-11-24
Combination Study of Antibiotics With Enzalutamide (PROMIZE)
Institute of Cancer Research, United Kingdom
Phase 1/2 Recruiting
Clinical Trials
1 trialsInterventional × Metastatic Castration-Resistant Prostate Cancer (mCRPC) × Metronidazole × Clear all